THE INTRAPATIENT VARIABILITY OF BLOOD LEVEL OF TACROLIMUS PREDICTS TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Ken Sagou, 266567

THE IMPACT OF PRE-TRANSPLANT CELL-FREE DNA LEVELS ON LEUKEMIA RELAPSE AND TRANSPLANT RELATED COMPLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS

EHA Library, Zeynep Arzu Yegin, 266568

OUTCOMES FOR MELPHALAN-VELCADE BASED AUTOGRAFT IN HIGH RISK MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTRE EXPERIENCE

EHA Library, David ROUTLEDGE, 266569

CHIMERISM MONITORING BY QPCR, A ROBUST PERFORMANCE FROM 0.05% TO 100%

EHA Library, Evelien Bouwmans, 266570

THE CHARLSON COMORBIDITY INDEX PREDICTS OUTCOMES FOR ELDERLY PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Sheng-Hsuan Chien, 266571

LOWER SERUM LEVELS OF ZINC AND MAGNESIUM ARE ASSOCIATED WITH WORSE ORAL CGVHD AND DYSGEUSIA IN CGVHD PATIENTS

EHA Library, Maria Radman, 266572

EXCELLENT OUTCOME OF MATCHED DONOR AND HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH TARGETED BUSULFAN-BASED MYELOABLATIVE CONDITIONING IN PATIENTS WITH NONMALIGNANT GENETIC DISEASES.

EHA Library, Kyung Taek Hong, 266573

MONOSOMY 7 ALONE OR WITH OTHER CHROMOSOMAL ABNORMALITIES SIGNIFICANTLY AFFECT SURVIVAL OF SECONDARY AML PATIENTS TREATED WITH ALLOGENEIC- SCT

EHA Library, Mona Hassanein, 266574

HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING REDUCED-INTENSITY CONDITIONING FOR PEDIATRIC PATIENTS WITH FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Chenguang Jia, 266575

IMMUNOLOGICAL RECONSTITUTION AS A BASIS FOR THE EARLY INITIATION OF PNEUMOCOCCAL VACCINATION AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Igor Iskrov, 266576

ANALYSIS OF CENTRAL NERVOUS SYSTEM COMPLICATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, cristina insua vilas, 266577

VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT -80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS

EHA Library, Ivan Tonev, 266578

STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA: THE ROLE OF THE CONDITIONING REGIMEN

EHA Library, SABRINA GIAMMARCO, 266579

FATTY ACID OXIDATION AND MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION REGULATE T-CELL EFFECTOR FUNCTION DURING GRAFT-VERSUS-HOST DISEASE.

EHA Library, Hirofumi Nakano, 266580

MNPSEQ AS A HIGHLY SENSITIVE METHOD FOR DETECTING CHIMERISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, xiaodong lyu, 266581

TREG DOWNREGULATION IS ASSOCIATED WITH INCREASE OF T CELL RESPONSES AGAINST IMMUNOGENIC ANTIGENS AND CLINICAL RESPONSES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER DONOR LYMPHOCYTE INFUSION

EHA Library, Jochen Greiner, 266582

COMPARISON OF ALEMTUZUMAB, ANTI-THYMOCYTE GLOBULIN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE GRAFT-VS-HOST DISEASE AND GRAFT-VS-LEUKEMIA EFFECT IN XENOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.

EHA Library, Kiyomi Mashima, 266583

CHANGING CAUSES OF MORTALITY IN TDT DURING THE ERA OF ORAL CHELATION THERAPY FROM 2000 TO 2018

EHA Library, Petros Kountouris, 266584

REDUCTION OF CARDIAC OUTCOMES IN THALASSEMIA MAJOR THANKS TO A TEN-YEAR NATIONAL ITALIAN NETWORKING

EHA Library, Antonella Meloni, 266585

THE EFFICACY OF ALENDRONATE FOR THE TREATMENT OF THALASSEMIA-ASSOCIATED OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Pokpong Piriyakhuntorn, 266586

DATA FROM THE FRENCH REGISTRY FOR BETA-THALASSEMIA PATIENTS

EHA Library, Catherine Badens, 266587

8-YEARS' OVERALL AND EVENT FREE SURVIVAL IS SUBOPTIMAL IN A LARGE GROUP OF TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS

EHA Library, Antonis KATTAMIS, 266588

RELATIONSHIP BETWEEN LIVER IRON CONCENTRATION MEASURED BY MRI T2* AND SERUM FERRITIN IN HEMOGLOBIN H DISEASE

EHA Library, Ka Lok Chan, 266589

IMPAIRMENT OF GLUTATHIONE SYSTEM AND LIPID PEROXIDATION IN PATIENTS WITH HB H DISEASE

EHA Library, Antonis KATTAMIS, 266590

IDENTIFICATION OF REFERENCE GENES IN HUMAN TUMORS FOR TUMOR EDUCATED PLATELETS (TEPS) STUDY BASED ON RNA-SEQ DATA

EHA Library, Huaichao Luo, 266591

FUNCTIONAL ACTIVITY OF PLATELETS IN THE APPLICATION OF OLIGOPEPTIDES CONTAINING РROLINE AND ARGININE

EHA Library, Marina Grigorjeva, 266592

DETECTION OF ANTIBODIES DIRECTED AGAINST DOMAIN 1 OF BETA 2 GLYCOPROTEIN I IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME 

EHA Library, Adrienne Kerényi, 266593

EXPLORING THE REAL-LIFE CLINICAL VALUE OF LOW DOSE DIRECT ANTICOAGULANTS FOR SECONDARY PREVENTION OF THROMBOEMBOLISM

EHA Library, Charalampos Kartsios, 266594

THE EFFECT OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODY UPON THROMBIN GENERATION IN NORMAL, LEIDEN HETEROZYGOUS AND FACTOR DEFICIENT PLASMAS

EHA Library, Gabor Szabo, 266595

APAC, A DUAL ANTIPLATELET AND ANTICOAGULANT - TOWARDS A LOCAL, VASCULAR TARGETING ANTITHROMBOTIC

EHA Library, Riitta Lassila, 266596

ANTITHROMBOTIC EFFECT OF SULFATED NON-ANTICOAGULANT HEPARIN WITHOUT COMPROMIZING HEMOSTASIS

EHA Library, Shaker Mousa, 266597

SULFATED NON-ANTICOAGULANT LOW MOLECULAR WEIGHT HEPARIN (S-NACH) IN COMBATING CANCER ASSOCIATED THROMBOSIS WITHOUT EFFECTS ON HEMOSTASIS

EHA Library, Shaker Mousa, 266599

DASATINIB ATTENUATES THROMBIN GENERATION AND CLOT RETRACTION OF CONVULXIN ACTIVATED HUMAN PLATELETS

EHA Library, János István Kappelmayer, 266600

ANTICOAGULANT THERAPY IN THROMBOCYTOPENIC PATIENTS WITH BLOOD CANCER AND CATHETER-RELATED VTE: RESULTS FROM A DELPHI CONSENSUS ON PLATELETS COUNT BELOW 50 X 109L

EHA Library, S Siragusa, 266601

VON WILLEBRAND FACTOR DELAYS LIVER REPAIR AFTER ACETAMINOPHEN-INDUCED ACUTE LIVER INJURY IN MICE.

EHA Library, Dafna Groeneveld, 266602

SEC22B-DEPENDENT TRAFFICKING IS ESSENTIAL FOR VWF MULTIMERIZATION AND FORMATION OF ELONGATED WPBS

EHA Library, Ellie Karampini, 266603

INCIDENCE, CLINICAL FEATURES, RISK FACTORS AND OUTCOMES OF REFRACTORY ACQUIRED IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: A CHINESE MULTI-CENTER EXPERIENCE

EHA Library, Ruo-Yun Gui, 266604

SEPSIS INDUCED MRNA AND MIRNA LEVELS IN MEGAKARYOCYTES AND PLATELETS GENERATE ADVERSE PLATELET REACTIVITY

EHA Library, Bernadett Szilágyi, 266605

TREATMENT OF SEVERE INFECTIONS IN NEUTROPENIC PATIENTS WITH GRANULOCYTE TRANSFUSIONS: A SINGLE CENTRE EXPERIENCE IN 57 PATIENTS TREATED WITH 603 TRANSFUSIONS

EHA Library, Nika zima, 266606

COMPARISON BETWEEN COBE SPECTRA® AND SPECTRA OPTIA® APHERESIS SYSTEMS FOR HEMATOPOIETIC PROGENITOR CELLS (HPC) COLLECTION IN HEALTHY DONORS: SINGLE CENTRE EXPERIENCE

EHA Library, Beatriz Aguado Bueno, 266607

ARE NATIONAL GUIDELINES AND MANDATORY TRAINING ENOUGH TO ENSURE SAFE TRANSFUSION PRACTICE?

EHA Library, Silvia Lovato, 266608

ABO INCOMPATIBLE KIDNEY TRANSPLANTATION - ONE CENTRE EXPERIENCE

EHA Library, Marco Sampaio, 266609

PREVALENCE OF RHD VARIANTS AMONGST A PORTUGUESE BLOOD DONOR CENTRE

EHA Library, Marco Sampaio, 266610

INTRAVENOUS IRON SUPPLEMENTATION PROTOCOL FOR POST-PARTUM ANEMIA

EHA Library, Elisabetta Volpato, 266611

PROFILE OF BLOOD DONORS WITH SEROLOGIC TESTS REACTIVE IN HOSPITAL METROPOLITANO IN QUITO- ECUADOR FROM JANUARY 2016 TO DECEMBER 2018.

EHA Library, Johanna Rojas Noboa, 266612

KNOWLEDGE, ATTITUDES AND PRACTICES ON BLOOD TRANSFUSION OF MEDICAL RESIDENTS IN A TERTIARY HOSPITAL: A QUESTIONNAIRE-BASED STUDY

EHA Library, RMIN SHEILA MIRANDA, 266613

IMPROVING QUALITY IN TRANSFUSION: GAIN LIFE OPTIMIZE RESOURCES

EHA Library, Maria Yuste, 266614

DEFORMABILITY OF PACKED RED BLOOD CELLS: UNIT-TO-UNIT VARIABILITY.

EHA Library, Gregory Barshtein, 266615

INTENSIVE PLAN OF THERAPEUTIC PLASMA EXCHANGE IN PATIENT WITH EXTREME HYPERTRLIGLYCERIDEMIA DUE TO L-ASPARAGINASE IN THE CONTEXT OF SMILE PROTOCOL IN T/NK NASAL LYMPHOMA TREATMENT

EHA Library, Eduardo Sobejano, 266616

DEVELOPMENT OF DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE IN A MURINE MODEL OF JAK2V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASM

EHA Library, Huichun Zhan, 267057

TARGETED NEXT-GENERATION SEQUENCING IDENTIFIES NOVEL GENE VARIANTS IN JAK2V617F NEGATIVE PATIENTS WITH ERYTHROCYTOSIS AND JAK2 GGCC_46/1 HAPLOTYPE

EHA Library, Francesco ALBANO, 267061

Emerging immunotherapy in MDS and AML: The bridge between innate and

EHA Library, Arjan van de Loosdrecht, 273522

IMPACT OF CONDITIONING INTENSITY OF ALLOGENEIC TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH GENOMIC EVIDENCE OF RESIDUAL DISEASE

EHA Library, Christopher Hourigan, 273253

Sequencing therapy for relapsed/refractory CLL

EHA Library, Florence Cymbalista, 274156

FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES

EHA Library, Kirsten Fischer, 267350

TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICE

EHA Library, Antonella Nai, 267349

RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE

EHA Library, J Howard, 267348

DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESIS

EHA Library, Sofia Gialesaki, 267347

Impact of the gut microbiota on immunomodulation

EHA Library, Bastiaan Haak, 274164

Immune side of MDS

EHA Library, Shahram KORDASTI, 274167

There is a definite need for DOAC testing in emergency situations and elective preoperative settings!

EHA Library, Marc Samama, 274216

David Grimwade Lecture: The bone marrow microenvironment dual roles: Regulation of hematopoiesis and stem cell protection

EHA Library, Tsvee Lapidot, 273521

José Carreras Lecture Award

EHA Library, Michael Hallek, 273520

Young EHA Best Abstract Awards

EHA Library, María-Victoria Mateos, 277631

EHA Research & Mobilty Grants

EHA Library, Sabine Eichinger, 277630

IMPACT OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN CORD BLOOD TRANSPLANTATION ON BEHALF OF THE TRANSPLANT COMPLICATIONS WORKING GROUP OF JSHCT

EHA Library, Shigeo Fuji, 267319

THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMA

EHA Library, Arnold Bolomsky, 267323

TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE NEGATIVE RESPONSES AFTER LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA

EHA Library, Tanya Siddiqi, 267310

GENETICS AND MODELING OF HUMAN ACUTE ERYTHROID LEUKEMIA

EHA Library, Alexandre Fagnan, 267314

CHRONIC MYELOID LEUKEMIA IS ASSOCIATED WITH INCREASED NEUTROPHIL EXTRACELLULAR TRAP FORMATION THAT IS AUGMENTED BY PONATINIB - A POTENTIAL CONTRIBUTOR TO VASCULAR TOXICITY?

EHA Library, Ofir Wolach, 267328

IL7R EXPRESSION PREDICTS T-ALL SENSITIVITY TO JAK INHIBITORS REGARDLESS OF IL7R/JAK/STAT MUTATIONAL STATUS

EHA Library, Ludovic Lhermitte, 267214

NGS-BASED COPY-NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMS

EHA Library, Ryunosuke Saiki, 267336

JUNCTIONAL ADHESION MOLECULE A (JAM-A) IS A CRITICAL REGULATOR OF HSC HOMING AND MAINTENANCE OF STEM CELL QUIESCENCE

EHA Library, Ben Cao, 267340

A MULTICENTRE, RANDOMIZED, NON-INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION-DEPENDENT HEMOGLOBINOPATHIES (DEEP-2 TRIAL)

EHA Library, Antonis KATTAMIS, 267345

THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIAL

EHA Library, Enrico Tiacci, 267305

THE ROLE OF ANTI-THYMOCYTE GLOBULIN WITH THIOTEPA-BUSULFAN-FLUDARABINE BASED CONDITIONING IN PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANT AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

EHA Library, Jean El Cheikh, 267318

MLL FUSIONS AFFECT SPLICING TO INDUCE EXPLOITABLE METABOLIC DEPENDENCIES

EHA Library, Robert Slany, 267313

SINGLE-CELL CHARACTERIZATION OF THE MULTIPLE MYELOMA (MM) IMMUNE MICROENVIRONMENT IDENTIFIES CD27- T CELLS AS POTENTIAL SOURCE OF TUMOR-REACTIVE LYMPHOCYTES

EHA Library, CIRINO BOTTA, 267322

COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS.

EHA Library, Chinmay Munje, 267327

TRANSIENT SUBCLONES CARRYING NT5C2 MUTATIONS DEFINE A HIGH-RISK PATIENT GROUP WITH POOR OUTCOME IN PEDIATRIC RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Malwine Pogodzinski, 267331

SAFETY ANALYSIS OF VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): SECOND INTERIM ANALYSIS FROM THE PHASE II VISION HO141 TRIAL

EHA Library, Arnon Kater, 267309

CLONAL HEMATOPOIESIS IN ELDERLY TWINS : CONCORDANCE, DISCORDANCE AND SURVIVAL

EHA Library, Jakob Werner Hansen, 267335

A DISTINCT WAVE OF HSC-DERIVED T CELL-ILC-RESTRICTED PROGENITORS INITIATES THE EMBRYONIC THYMUS

EHA Library, Ramy ELSAID, 267339

LUSPATERCEPT INCREASES FETAL HEMOGLOBIN (HBF) LEVELS IN ADULT Β-THALASSEMIA PATIENTS WHO REQUIRE RED BLOOD CELL (RBC) TRANSFUSIONS

EHA Library, Maria-Domenica Cappellini, 267344

OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIAL

EHA Library, Steven Le, 267304

A BUSULFAN FOLLOWING CYCLOPHOSPHAMIDE, PROTOCOL IMPROVED RESULTS IN ALTERNATIVE DONOR TRANSPLANT FOR PATIENTS WITH THALASSEMIA MAJOR: A RESULT FROM LONG-TERM LARGE-SIZE MULTI-CENTER STUDY IN CHINA

EHA Library, Chunfu Li, 267317

FIVE-YEAR FOLLOW-UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Alessandra Tedeschi, 267308

FIRST-IN-CLASS ORAL FERROPORTIN INHIBITOR: MODE OF ACTION AND EFFICACY IN A MOUSE MODEL OF BETA-THALASSEMIA INTERMEDIA

EHA Library, Vania Manolova, 267343

POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIAL

EHA Library, pau abrisqueta, 267303

PATHWAY AND GENE SET OVERDISPERSION ANALYSIS OF SINGLE CELL TRANSCRIPTOMIC DATA FROM PATIENTS WITH CHRONIC MYELOID LEUKAEMIA HIGHLIGHTS TRANSCRIPTIONAL HETEROGENEITY IN CD34+CD38- CELLS

EHA Library, William Dunn, 267326

CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT Β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDY

EHA Library, Mark C. Walters, 267342

DNA METHYLATION DYNAMICS IDENTIFY LINEAGE-SPECIFIC REGULATION PATTERNS OF HEMATOPOIETIC DIFFERENTIATION

EHA Library, Sina Stäble, 267338

EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: RESULTS OF THE PHASE III MABCUTE STUDY

EHA Library, Simon Rule, 267302

TP53 SOMATIC MUTATIONS AS PRE-LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Guranda Chitadze, 267330

IDENTIFICATION OF THE DOPAMINE AND SEROTONIN TRANSPORTERS SLC6A3 AND SLC6A4 AS NOVEL SURVIVAL FACTORS IN LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKAEMIA

EHA Library, Abdulkarim Aldosari, 267325

CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST?

EHA Library, Mehmet Samur, 267321

IMPACT OF MESURABLE RESIDUAL DISEASE POSITIVITY ON OUTCOMES FOLLOWING UNMBILICAL CORD BLOOD TRANSPLANTATION : A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT AND EUROCORD

EHA Library, Frederic Baron, 267316

SIRT5 IS REQUIRED FOR ACUTE MYELOID LEUKEMIA GROWTH AND SURVIVAL AND MAY REPRESENT A NOVEL THERAPEUTIC TARGET

EHA Library, Michael W Deininger, 267312

HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL

EHA Library, Othman Al-Sawaf, 267307

EX VIVO DRUG SENSITIVITY PROFILING IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS DEFINES NOVEL DRUG SENSITIVITY PATTERNS FOR PREDICTING CLINICAL THERAPEUTIC OUTCOMES

EHA Library, Alexey Aleshin, 267334